[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336155-105":59,"doc-detail-336155-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","new-treatment-alternatives-for-primary-and-metastatic-colorectal-cancer-by-an-integrated-transcriptome-and-network-analyses-research-article","New treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses - Research Article","","Metastatic colorectal cancer (CRC) requires more effective therapies. This study presents an integrated, holistic analysis of primary CRC and liver metastatic CRC samples, using co-expression network grouping of microarray data to identify gene modules linked to primary and metastatic phenotypes. Network clustering and pathway enrichment prioritize candidate targets, validated independently. Drug-target interaction screening narrows candidates to three agents, including Hesperadin and BAY-1217389, plus IL-29A, which suppresses migration and invasion and modulates TGF-β–driven mesenchymal transition via JAK/STAT signaling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/new-treatment-alternatives-for-primary-and-metastatic-colorectal-cancer-by-an-integrated-transcriptome-and-network-analyses-research-article/336155/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/new-treatment-alternatives-for-primary-and-metastatic-colorectal-cancer-by-an-integrated-transcriptome-and-network-analyses-research-article/336155.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What research question does the study address about colorectal cancer treatment?","Question",{"text":112,"@type":113},"The study addresses the need for improved treatments for primary and metastatic (especially liver metastatic) colorectal cancer by proposing new therapeutic targets and evaluating their potential in vitro.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were candidate targets identified in this integrated workflow?",{"text":117,"@type":113},"Primary and metastatic CRC samples were grouped using co-expression network analysis to detect significant gene modules. Network clustering and pathway enrichment prioritized potential targets, which were then shortlisted through independent validation and supported by drug-target interaction searches.",{"name":119,"@type":110,"acceptedAnswer":120},"What did IL-29A treatment demonstrate in metastatic CRC models?",{"text":121,"@type":113},"IL-29A reduced migration and invasion capacities of TGF-β induced metastatic cell lines and attenuated TGF-β dependent mesenchymal transition. Network analysis indicates IL-29A induces the JAK/STAT pathway in a preventive manner.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336155,1790217033,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nNew treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses  \nCaner Karaca1,6, Ezgi Demir Karaman2,6, Asim Leblebici1, Hasan Kurter1, Hulya Ellidokuz 3, Altug Koc1, Ender Berat Ellidokuz4, Zerrin Isik2* & Yasemin Basbinar 5*  \nMetastatic colorectal cancer (CRC) is still in need of effective treatments. This study applies a holistic approach to propose new targets for treatment of primary and liver metastatic CRC and investigates their therapeutic potential in-vitro. An integrative analysis of primary and metastatic CRC samples was implemented for alternative target and treatment proposals. Integrated microarray samples were grouped based on a co-expression network analysis. Significant gene modules correlated with primary CRC and metastatic phenotypes were identified. Network clustering and pathway enrichments were applied to gene modules to prioritize potential targets, which were shortlisted by independent validation. Finally, drug-target interaction search led to three agents for primary and liver metastatic CRC phenotypes. Hesperadin and BAY-1217389 suppress colony formation over a 14-day period, with Hesperadin showing additional efficacy in reducing cell viability within 48 h. As both candidates target the G2/M phase proteins NEK2 orTTK, we confirmed their anti-proliferative properties by Ki-67 staining. Hesperadinin particular arrested the cell cycle at the G2/M phase. IL-29A treatment reduced migration and invasion capacities ofTGF-β induced metastatic cell lines. In addition, this anti-metastatic treatment attenuated TGF-β dependent mesenchymal transition. Network analysis suggests IL-29A induces the JAK/STAT pathway in a preventive manner.  \nMetastasis is the major cause of death in patients with colorectal cancer1. The most common metastasis sites of colorectal cancer are the liver, followed by the lung, lymph node, and peritoneum2. Chemotherapy, immunotherapy, targeted therapy, and their combinations are used for metastatic colorectal cancer (CRC) treatment3. Even despite these current therapies, metastatic CRC still needs enhanced treatments.  \nCell cycle regulators have emerged as prominent targets in cancer treatment, considering that cancer is fundamentally characterized by uncontrolled proliferation. Various chemotherapeutic agents aim to hinder the function of checkpoint proteins involved in cell division, particularly cyclin-dependent kinases (CDKs), to impede the signaling for cell division. FDA-approved examples are palbociclib, ribociclib, and abemaciclib, which specifically inhibit CDK 4/6. Similarly, the regulation of the G2/M transition and the proper separation of sister chromatids during mitosis have been targeted to obstruct cell division and induce aneuploidy. This approach is frequently employed, often in combination with other chemotherapy drugs, utilizing aurora kinase inhibitors and taxane-based chemotherapeutics in the treatment of various cancers.  \nThe IL-10 family consists ofa wide range of cytokines. IL-28A, IL-28B, and IL-29 form the subfamily of IL-204. IL-29 exhibits multiple biological activities including immune regulatory activity, anti-viral5, obesity-induced inflammation6, and anti-tumor properties7. IL-29 has been shown to have anti-tumor effects on many human cancer cells such as melanoma8, neuroendocrine cancer9, colorectal cancer10, and glioblastoma11. However, there  \n1Department of Translational Oncology, Institute of Health Sciences, Dokuz Eylul University, Izmir, Turkey. 2Department of Computer Engineering, Faculty of Engineering, Dokuz Eylul University, Izmir, Turkey. 3Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey. 4Department of Gastroenterology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey. 5Department of Translational Oncology, Institute of Oncology, Dokuz Eylul Uni","cbCaip9xD5wjJNDO","https://ap.wps.com/l/cbCaip9xD5wjJNDO","pdf",7433389,15,"English","# Background\n## Metastatic CRC challenges\n## Cell cycle regulators and current targeting strategies\n## IL-29 biology and research gap\n# Methods and Integrative Bioinformatics Approach\n## Co-expression network analysis and gene modules\n## Pathway enrichment and target prioritization\n## Independent validation and drug-target interaction search\n# Results and Therapeutic Implications\n## Agents suppress proliferation and cell viability\n## Cell-cycle arrest evidence\n## Anti-metastatic effects of IL-29A\n# Related Bioinformatics Studies","[{\"question\":\"What research question does the study address about colorectal cancer treatment?\",\"answer\":\"The study addresses the need for improved treatments for primary and metastatic (especially liver metastatic) colorectal cancer by proposing new therapeutic targets and evaluating their potential in vitro.\"},{\"question\":\"How were candidate targets identified in this integrated workflow?\",\"answer\":\"Primary and metastatic CRC samples were grouped using co-expression network analysis to detect significant gene modules. Network clustering and pathway enrichment prioritized potential targets, which were then shortlisted through independent validation and supported by drug-target interaction searches.\"},{\"question\":\"What did IL-29A treatment demonstrate in metastatic CRC models?\",\"answer\":\"IL-29A reduced migration and invasion capacities of TGF-β induced metastatic cell lines and attenuated TGF-β dependent mesenchymal transition. Network analysis indicates IL-29A induces the JAK/STAT pathway in a preventive manner.\"}]","New treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses - Research Article | PDF",1790013898,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e23e2975676f52269c0637811c91c9d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cd15a8fe17f82de42fd55375044d057.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ee9edcea1d5c4d393d9beffa8301cc3.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/356b6d19eb4268fef10a1bd2114cc406.webp",980,1287]